Non-alcohol fatty liver disease in Asia:Prevention and planning

被引:7
作者
Sara Ashtari [1 ]
Mohamad Amin Pourhoseingholi [1 ]
Mohamad Reza Zali [1 ]
机构
[1] Gastroenterology and Liver Disease Research Center,Research Institute for Gastroenterology and Liver Diseases,Shahid Beheshti University of Medical Science
关键词
Non-alcoholic fatty liver disease; Metabolic risk factors; Asian countries; Prevention;
D O I
暂无
中图分类号
R575.5 [肝代谢障碍];
学科分类号
1002 ; 100201 ;
摘要
AIM:To review all of epidemiological aspects of nonalcoholic fatty liver disease(NAFLD) and also prevent this disease is examined.METHODS:We conducted a systematic review according to the PRISMA guidelines.All searches for writing this review is based on the papers was found in Pub Med(MEDLINE),Cochrane database and Scopus in August and September 2014 for topic of NAFLD in Asia and the way of prevention of this disease,with no language limitations.All relevant articles were accessed in full text and all relevant materials was evaluated and reviewed.RESULTS:NAFLD is the most common liver disorder in worldwide,with an estimated with 20%-30% prevalence in Western countries and 2%-4% worldwide.The prevalence of NAFLD in Asia,depending on location(urban vs rural),gender,ethnicity,and age is variable between 15%-20%.According to the many studies in the world,the relationship between NAFLD,obesity,diabetes mellitus,and metabolic syndrome(MS) is quiet obvious.Prevalence of NAFLD in Asian countries seems to be lower than the Western countries but,it has increased recently due to the rise of obesity,type 2 diabetes and MS in this region.One of the main reasons for the increase in obesity,diabetes and MS in Asia is a lifestyle change and industrialization.Today,NAFLD is recognized as a major chronic liver disease in Asia.Therefore,prevention of this disease in Asian countries is very important and the best strategy for prevention and control of NAFLD is lifestyle modifications.Lifestyle modification programs are typically designed to change bad eating habits and increase physical activity that is associated with clinically significant improvements in obesity,type 2 diabetes and MS.CONCLUSION:Prevention of NAFLD is very importantin Asian countries particularly in Arab countries because of high prevalence of obesity,diabetes and MS.
引用
收藏
页码:1788 / 1796
页数:9
相关论文
共 54 条
[31]  
Prevalence and Risk Factors of Nonalcoholic Fatty Liver Disease in an Adult Population of Taiwan: Metabolic Significance of Nonalcoholic Fatty Liver Disease in Nonobese Adults[J] . Chien-Hua Chen,Min-Ho Huang,Jee-Chun Yang,Chiu-Kue Nien,Chi-Chieh Yang,Yung-Hsiang Yeh,Sen-Kou Yueh.Journal of Clinical Gastroenterology . 2006 (8)
[32]  
Prevalence of obesity, central obesity and the associated factors in urban population aged 20–70?years, in the north of Iran: a population‐based study and regression approach[J] . K. O.Hajian‐Tilaki,B.Heidari.Obesity Reviews . 2006 (1)
[33]   A double-blind randomized placebo-controlled trial of orlistat for the treatment of nonalcoholic fatty liver disease [J].
Zelber-Sagi, Shira ;
Kessler, Ada ;
Brazowsky, Eli ;
Webb, Muriel ;
Lurie, Yoav ;
Santo, Moshe ;
Leshno, Moshe ;
Blendis, Laurence ;
Halpern, Zamir ;
Oren, Ran .
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2006, 4 (05) :639-644
[34]   Epidemic obesity and type 2 diabetes in Asia [J].
Yoon, Kun-Ho ;
Lee, Jin-Hee ;
Kim, Ji-Won ;
Cho, Jae Hyoung ;
Choi, Yoon-Hee ;
Ko, Seung-Hyun ;
Zimmet, Paul ;
Son, Ho-Young .
LANCET, 2006, 368 (9548) :1681-1688
[35]   Prevalence of metabolic syndrome and its relationship to white blood cell count in a population of Thai men and women receiving routine health examinations [J].
Lohsoonthorn, V ;
Dhanamun, B ;
Williams, MA .
AMERICAN JOURNAL OF HYPERTENSION, 2006, 19 (04) :339-345
[36]  
Prevalence of the metabolic syndrome among Korean adults using the new International Diabetes Federation definition and the new abdominal obesity criteria for the Korean people[J] . Hee Man Kim,Dae Jung Kim,In Hyun Jung,Chanwang Park,Jong Park.Diabetes Research and Clinical Practice . 2006 (1)
[37]  
Prevalence of metabolic syndrome in Iranian adult population, concordance between the IDF with the ATPIII and the WHO definitions[J] . Azadeh Zabetian,Farzad Hadaegh,Fereidoun Azizi.Diabetes Research and Clinical Practice . 2006 (2)
[38]  
Metabolic syndrome—a new world‐wide definition. A Consensus Statement from the International Diabetes Federation[J] . K. G. M. M.Alberti,P.Zimmet,J.Shaw.Diabetic Medicine . 2006 (5)
[39]  
Weight Loss as a Treatment for Nonalcoholic Fatty Liver Disease[J] . Jeanne M Clark.Journal of Clinical Gastroenterology . 2006
[40]   Prevalence and risk factors of non-alcoholic fatty liver disease among Korean adults [J].
Park, SH ;
Jeon, WK ;
Kim, SH ;
Kim, HJ ;
Park, DI ;
Cho, YK ;
Sung, IK ;
Sohn, CI ;
Keum, DK ;
Kim, BI .
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2006, 21 (01) :138-143